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Although evidence on myelin diseases is steadily accumulating, effective preventive or 
therapeutic strategies against them have not been established so far. Ginseng is well 
known for its beneficial effects on health and diseases; however, detailed studies on 
ginseng’s effects on myelin-producing oligodendrocytes have not been performed yet. In 
this study, we investigated the function of gintonin—an active component of ginseng—on 
the proliferation, differentiation, and survival of oligodendrocyte lineage cells. We performed 
real-time percutaneous coronary intervention, Western blot, and immunocytochemistry on 
primary oligodendrocyte precursor cell cultures and in vitro myelinating co-cultures. Our 
results show that gintonin stimulates oligodendrocyte precursor cell proliferation. Gintonin’s 
effect was inhibited by Ki16425, an antagonist of lysophosphatidic acid 1/3 receptors. 
Interestingly, with regard to cell differentiation, gintonin facilitated late differentiation of 
oligodendrocyte development, but not early differentiation. Moreover, it showed protective 
effects on oligodendrocyte lineage cells against endoplasmic reticulum stress-induced 
cell death, potentially by modulating unfolded protein responses. Our results suggest that 
gintonin is a potential therapeutic candidate in the treatment of myelin diseases.
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INTRODUCTION
Oligodendrocytes are glial cells that synthesize myelin, a material that wraps around axons 
and facilitates neuronal conduction in the central nervous system (Hughes and Appel, 2016). 
Oligodendrocytes are derived from oligodendrocyte precursor cells (OPCs). Expression of 
transcription factors gradually changes along the developmental stages of oligodendrocyte lineage 
cells (Dwight E, 2016). During OPC development, certain transcription factors are specifically 
expressed during the specific developmental stages. For example, Hes5, Id2, Id4, Sox5, and Sox6 
are expressed during the OPC stage and Myrf, Zfhx1b, Smad7, and Nkx6-2 are expressed for the 
later stages (Cahoy et al., 2008). OPCs comprise approximately 5–8% of the glial cell population 
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in adults. In demyelinating conditions, OPCs have the ability to 
differentiate into myelinating oligodendrocytes to replace the lost 
myelin (Levine et al., 2001). The number of OPCs is significantly 
reduced in demyelinated lesions from postmortem patients with 
multiple sclerosis (Lucchinetti et al., 1999; Chang et al., 2000; 
Boyd et al., 2013), suggesting abnormal homeostatic control 
of myelination.
OPCs are highly vulnerable to stress because their metabolic 
rate and intracellular iron are high, while their concentrations 
of the antioxidant glutathione are low (Bradl and Lassmann, 
2010). Oligodendrocytes produce huge amounts of myelin, 
and they are hypersensitive to homeostatic alterations such 
as endoplasmic reticulum (ER) stress (Lin and Popko, 2009). 
ER stress in myelinating oligodendrocytes plays critical role in 
causing myelin diseases such as Pelizaeus–Merzbacher disease, 
Charcot–Marie–Tooth disease, vanishing white matter disease, 
and multiple sclerosis (Lin and Popko, 2009). Under ER stress 
conditions, translation is repressed most rapidly (Harding 
et al., 2000), leading to cell death in actively (re)myelinating 
oligodendrocytes (Lin and Popko, 2009).
The components of gintonin include lysophosphatidic acids 
(LPAs), ginseng major latex-like protein 151, and ginseng 
ribonuclease-like storage protein (Hwang et al., 2012). Gintonin 
is a high-affinity ligand for mammalian GTP-binding protein-
coupled LPA receptors (Hwang et al., 2012). Its functions have 
been mainly reported in neurons and astrocytes, and those in 
oligodendrocytes have not been investigated yet.
The pathogenesis of the myelin diseases can derive from 
various stages of oligodendrocyte development, including 
proliferation, differentiation, and myelination. In this study, 
we evaluated whether gintonin can modulate the behavior 
of oligodendrocyte lineage cells under physiological and 
pathological conditions. We examined whether gintonin changes 
OPC proliferation and differentiation during cell development 




All primary cultures were performed in compliance with the 
relevant laws and institutional guidelines and were approved 
by the University of Brain Education’s Animal Care and Use 
Committee (Approval number: 2017-AE-01). Timed pregnant 
females (day 13.5 of pregnancy) or pups (postnatal day 0–1) of 
CrljOri : CD1(ICR) mouse line were purchased from ORIENT 
BIO Inc. (Seongnam, Korea).
Materials
Six-year-old Korean ginsengs were purchased from local ginseng 
market and identified by Professor SY Nah, and the specimen 
(voucher number: NIBRVP0000730014) was deposited at the 
herbarium of the National Institute of Biological Resources 
(Herbarium Code: KB, http://sweetgum.nybg.org/science/ih/
herbarium-details/?irn=138656). Gintonin was prepared as 
previously described (Mi Kyung Pyo et al., 2011). Ki16425 was 
purchased from Cayman Chemicals (Ann Arbor, MI, USA). 
Tunicamycin was purchased from Sigma-Aldrich (St Louis, 
MO, USA). Culture medium and reagents were purchased from 
Invitrogen (Carlsbad, CA, USA).
Cell Cultures
For OPC cultures, glia mixed culture was prepared in advance. 
To perform glia mixed cultures, zero to one day old ICR mice 
were sacrificed for collection of brains. Mouse cortices were 
separated in L15 on ice and collected into 15 ml falcon tubes, 
then gently broken down twice with 19xneedles and twice with 
21× needles in precooled DMEM/penicillin-streptomycin. 
Proliferation medium (DMEM F12, 10% fetal bovine serum, 5% 
horse serum, and 1% penicillin-streptomycin) was added up to 
10–15 ml and centrifuged at 1000×g for 5 min. The cell pellet 
was re-suspended in the proliferation medium and transferred 
to poly-D-lysine (PDL)-coated 75 cm2 cell culture flasks. After 
adding the medium up to 15 ml, cultures were mildly agitated 
for equivalent distribution of the glial cells. Glial cells were 
incubated in the proliferation medium at 37°C in a humidified 
atmosphere with 5% CO2. Old medium was replaced with fresh 
medium every 3 days.
For OPC isolation, on days in vitro (DIV) 10 of glia mixed 
cultures, the medium was aspirated and 10 ml of fresh proliferation 
medium was added to the culture flask. The flask was vigorously 
shaken 30 times in a horizontal motion to detach the cells. After 
observing the OPC detachment under microscope, the medium 
was collected and centrifuged at 1000×g for 5 min. The cell pellet 
was re-suspended in the proliferation medium for proliferation 
assay and differentiation medium (DMEM containing 1× B-27 
supplement, 1× Glutamax, 1× penicillin–streptomycin, 1% horse 
serum, 1× sodium pyruvate, 0.34 μg/ml T3, and 0.4 μg/ml T4) for 
differentiation assays and coculture medium (DMEM containing 
B-27 supplement, N-2 supplement, 5 μg/ml N-Acetyl-Cysteine, 
5 μM forskolin, and penicillin–streptomycin) for myelinating 
cocultures. Resuspended pellets were incubated on the surface 
of the petri dishes for 2 min in order to remove astrocytes and 
transferred carefully for seeding. A number of 4–8 × 104 OPC 
cells per well were seeded in the 24-well plates.
For cocultures, mouse dorsal root ganglion (DRG) neuronal 
cultures were separately prepared paralleled with glia mixed 
cultures. DRGs were dissected out from embryonic 13.5 mouse 
embryos and dissociated with trypsin and the dissociated neurons 
were plated 3–4 × 104 cells per slide. Neurons were maintained 
in neurobasal medium (neurobasal medium containing 1× B-27 
supplement, 1× Glutamax, 0.05μg/ml Nerve Growth Factor 
(NGF), 1× penicillin–streptomycin) with or without FuDR cycle 
of every two days to induce cell cycle arrest to all proliferating 
cells. After 2 weeks, NGF was removed from the medium and the 
neurons were ready for cocultures with OPCs (Yang et al., 2016).
Lactate Dehydrogenase  
Cytotoxicity Assay
Cell viability was measured using lactate dehydrogenase (LDH) 
cytotoxicity detection kit (Takara Bio Inc., Mountain View, CA, 
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USA). 2.7×104 cells suspended in 100 µl of proliferation medium 
were plated in each well of a 96-well plate and incubated at 37°C 
and with 5% CO2 in a humidified atmosphere for overnight. 
Cells were then treated with gintonin along with tunicamycin 
in fresh medium and incubated overnight. After incubation, 
the microtiter plate was centrifuged at 250×g for 10 min; 70 
µl of supernatant was mixed with 70 µl of reaction mixture 
and incubated for 30 min at RT in darkness. Absorbance was 
measured at 490 nm and the cell viability was calculated as 
manufacturer’s instructions.
Quantitative Real-Time Polymerase  
Chain Reaction
Total RNA of OPC cultures or DRG/OPC cocultures was extracted 
using TRI reagent (Sigma-Aldrich, St. Louis, MO, USA) following 
the manufacturer’s instructions. cDNA was generated using 
Superscript First-Strand Synthesis System for RT-PCR (Thermo 
Fisher Scientific). Real-time polymerase chain reaction (PCR) 
was performed using PowerUp SYBR Green Master Mix (Life 
Technologies, Austin, TX, USA). All reactions were carried out in 
triplicate and the expression of each target gene was normalized with 
GAPDH. Specific primer sets for target genes were used as follows: 
ID2 (forward, 5′-CCTGCATCACCAGAGACCTG-3′; reverse, 
5′-TTCGACATAAGCTCAGAAGGGAA-3′), ID4 (forward, 5′-AG 
GGTGACAGCATTCTCTGC-3′; reverse, 5′-CCGGTGGCTTG 
TTTCTCTTA-3′), SOX10 (forward, 5′-AGCCCAGGTGAAGA 
CAGAGA-3′; reverse, 5′-AGTCAAACTGGGGTCGTGAG-3′), 
Myrf (forward, 5′-TGGCAACTTCACCTACCACA-3′; reverse, 
5′-GTGGAACCTCTGCAAAAAGC-3′), myelin basic protein 
(MBP) (forward, 5′-CCAGAGCGGCTGTCTCTTCC-3′; reverse, 
5′-CATCCTTGACTCCATCGGGCGC-3′), GAPDH (forward, 
5′-GGTCGGTGTGAACGGATTTG-3′; reverse, 5′-TCGTTGA 
TGGCAACAATCTCCACT-|3′), Olig1 (forward, 5′-GCTCGCC 
CAGGTGTTTTGT-3′; reverse, 5′-GCATGGAACGTGGTTGGA 
AT-3′), 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNP) (forward, 
5′-GTTCTGAGACCCTCCGAAAA-3′; reverse, 5′-CCTTGGG 
TTCATCTCCAGAA-3′), proteolipid protein (PLP) (forward, 
5′-GGTACAGAAAAGCTAATTGAGACC-3′; reverse, 5′-GATGA 
CATACTGGAAAGCATGA-3′), BIP (forward, 5′-ACTCCGGCGT 
GAGGTAGAAA-3′; reverse, 5′-AGAGCGGAACAGGTCCAT 
GT-3′), GRP94 (forward, 5′-TGGGTCAAGCAGAAAGGAG-3′; 
reverse, 5′-TCTCTGTTGCTTCCCGACTT-3′), CHOP (forward, 
5′-CCACCACACCTGAAAGCAGAA-3′; reverse, 5′-AGGTGCCC 
CCAATTTCATCT-3′), and sXBP-1 (forward, 5′-AAGAACACG 
CTTGGGAATGG-3′; reverse, 5′-CTGCACCTGCTGCGGAC-3′).
Immunoblot Analysis
Western blot analysis was carried out to assess the expression of 
the desired proteins. Cells were harvested and directly lysed with 
sample buffer. Samples were separated by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis and transferred to polyvinylidene 
difluoride (PVDF), membranes (Bio-Rad Laboratories Inc., Hercules, 
USA). After blocking with 5% bovine serum albumin (RMBIO, 
Missoula, MT, USA)/tris buffered saline with tween 20 (TBST), the 
membranes were incubated overnight at 4°C with following primary 
antibodies: rat anti MBP (1:5000, Merck, Darmstadt, Germany), 
rabbit anti XBP-1s (1:1000, D2C1F, Cell Signaling Technology, Inc., 
Danvers, MA, USA), extracellular signal-regulated protein Kinase 
(ERK1/2, 1:20,000, sigma), phospho-p44/42 (1:2,000, Cell Signaling 
Technology, Inc.), and beta-actin (1:5000, Abcam, Cambridge, MA, 
USA) antibodies. The membranes were probed with following 
secondary antibodies: horseradish peroxidase conjugate goat anti-
rabbit IgG (1:5,000, Life Technologies, Frederick, MD, USA) or 
goat anti-rat IgG (1:10,000, Jackson ImmunoResearch Laboratories, 
Inc., West Groove, PA, USA) for 1 h at room temperature. Images 
were obtained using an Amersham Imager 600 (GE Healthcare, 
Pittsburgh, PA, USA) and quantified with Image J Software.
Immunofluorescence
For immunofluorescence, cells were fixed with 4% 
paraformaldehyde/phosphate-buffered saline (PBS) for 15 min 
at room temperature and blocked with PBS containing 5% 
normal goat serum, 0.5% Triton X-100 for 1 h, then stained 
with primary antibodies for overnight at 4°C. Cells were washed 
with PBS, incubated for 1 h with secondary antibodies, washed 
in PBS and mounted with Vectashield mounting solution 
(Vector Laboratories, Burlingame, CA, USA). Following 
primary antibodies were used for immunocytochemistry: rabbit 
antibodies to Olig 2 (1:500, AB9610, Millipore), ki67 (1:500, 
SP6, Cell Marque), rat antibody to MBP (1:300, MAB386, 
Chemicon), and hybridoma supernatants of mouse antibody 
to O4 (1:10). Secondary antibodies were obtained from Jackson 
Immunoresearch and Invitrogen. For O4 staining, cells were 
lively stained for 45 min in the incubator before fixation. Images 
were captured with a LSM700 confocal microscope (Carl Zeiss) 
and analyzed with Image J.
Statistical Analyses
All data were represented as mean ± S.E.M. Statistical analyses 
were performed using unpaired t-test, one- or two-way analysis of 
variance (ANOVA) with Tukey, Dunnett, or Bonferroni post hoc 
tests where appropriate. Differences were significant at p < 0.05.
RESULTS
Gintonin Enhances the Proliferation of 
Oligodendrocyte Lineage Cells
To understand whether gintonin affects the initial step of 
oligodendrocyte development, we investigated OPC proliferation 
by gintonin treatment at different concentrations and at various 
time points in the proliferation medium that was devoid of 
differentiation-inducing hormones such as T3 and T4. OPCs 
were isolated from mixed glial cultures at DIV10 by shaking, 
seeded on PDL-coated coverslips, and allowed to adhere. The 
purity of OPC cultures was investigated by calculating Olig2+cell 
number/DAPI+cell number (%) at DIV3 in proliferation 
medium. The OPC purity in our system was 91.0 ± 1.6% (mean ± 
S.E.M.) (Figure 1A). The medium was changed with fresh 
medium containing different concentrations of gintonin: 0, 0.1, 
1, 10, and 100 μg/ml. After 36, 48, and 60 h of seeding, cells 
were fixed for immunocytochemistry using an antibody against 
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proliferation marker Ki67 and DAPI (Figure 1B). There were 
no significant changes in the proliferation ratio (% Ki67/DAPI) 
until 48 h after seeding (Figures 1C, D, Supplementary Figures 
S1A–D); however, there was a concentration-dependent increase 
in the proliferation ratio at 60 h after seeding; 3.5, 6.0, 11.3, and 
17.2% for 0.1, 1, 10, and 100 μg/ml, respectively (Figures 1B, E, 
Supplementary Figures S1E, F). There were no significant 
changes in the proliferation of oligodendrocyte lineage cells 
treated with gintonin dissolved in the differentiation medium 
containing T3 and T4 at the same time points (Supplementary 
Figures S1G–I).
Previous studies have shown that gintonin containing LPAs 
acts through LPA receptors (Hwang et al., 2012; Choi et al., 
2019). As LPA1 and LPA3 expression on oligodendrocytes 
has been reported (Allard et al., 1998; Weiner et al., 1998; 
Yu et al., 2004), we made use of Ki16425, an antagonist of 
LPA1 and LPA3 receptors to investigate whether the increase 
of cell number was mediated by LPA1/3 receptors. OPCs 
were treated with the control proliferation medium, 10 μg/
ml gintonin with or without 1 μM Ki16425 during DIV1–3. 
The inhibitor was added 30 min before the incubation with 
gintonin, to block LPA1/3 receptors. Treating with Ki16425 
did not affect the OPC proliferation (Supplementary Figure 2) 
throughout this research, indicating that Ki16425 produced no 
cytotoxic effect on OPCs, which was consistent with a previous 
report (Nakajima et al., 2018). At DIV3, cells were fixed for 
proliferation analysis. Results from proliferation assay showed 
that the oligodendrocyte lineage cell number was significantly 
increased by gintonin treatment, while this increase was 
returned to the similar level of the control group by Ki16425 
(Figure 2), suggesting that the increase in cell proliferation by 
gintonin was mediated by LPA 1/3 receptors in OPCs.
FIGURE 1 | Gintonin enhances proliferation of oligodendrocyte lineage cells in dose- and time-dependent manner. (A) Representative image of OPC culture 
stainings to DAPI, olig2, and O4 in proliferation medium at DIV3 is shown. (B–E) OPCs were cultured in proliferation medium and incubated with gintonin of 0 to 100 
µg/ml for 36 (C), 48 (D), and 60 h (E). After the indicated time period, cells were fixed for staining of Ki67 and DAPI for proliferation analysis. Representative pictures 
at 60 h post seeding are shown (B). Significant increase was found in proliferation ratio of samples at 60 h post seeding (E) (*p < 0.05, **p < 0.01, one way ANOVA, 
Bonferroni post-test, N = 3–8). Bars represent mean ± S.E.M. Scale bars, 10 μm (A), 100 μm (B).
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Gintonin Affects Late-Stage Differentiation 
of Oligodendrocyte Lineage Cells But Not 
Early-Stage Differentiation
To see whether gintonin also affects the differentiation of 
oligodendrocyte lineage cells and whether it is occurred through 
LPA 1/3 receptors-mediated mechanisms or not, OPCs were 
suspended in the differentiating medium containing T3 and T4 
on the day of the seeding and incubated with reagent-containing 
differentiation medium during DIV1–3, followed by the cell 
collection at DIV3 for quantitative PCR (qPCR) on inhibitory 
(ID2, ID4) and facilitatory (SOX10, Myrf) transcription factors 
of differentiation (Figures 3A–D). The results showed that there 
were no significant changes in the expression of differentiation-
regulating transcription factors by gintonin and Ki16425, 
although there were slight reduction in ID2 (Figure 3A), ID4 
(Figure 3B) expression and mild increase in SOX10 (Figure 3C) 
and Myrf (Figure 3D) expression by gintonin treatment.
As MBP is the representative marker of mature 
oligodendrocytes, we investigated MBP expression depending 
on gintonin concentration (0.1, 1, 10, and 100 μg/ml) by qPCR at 
FIGURE 2 | Gintonin-induced proliferation is inhibited by Ki16425, a LPA 1/3 receptor antagonist. Pure OPC s were treated as indicated, with 10 μg/ml gintonin 
or 1 μM Ki16425 in the proliferation medium during DIV1–3 and fixed for proliferation analysis. (A–F) Cells were visualized by staining with DAPI (blue), antibodies 
to Ki67 (red), and MBP (green). Scale bars＝100 (A–C) and 10 µm (D–F). (G) DAPI+ cell number was automatically counted per field by image J. Cell number was 
significantly increased by gintonin treatment (*p < 0.05) and showed a tendency of downregulation by Ki16425 treatment (p = 0.08, one way ANOVA, Bonferroni 
post-test, N = 6–13). Bars represent mean ± S.E.M.
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DIV3 when a mixture of oligodendrocyte lineage cells of various 
developmental stages coexist. However, we found no significant 
changes in MBP expression in relation to the concentration of 
gintonin at DIV3 (Figure 3E). To see whether the MBP protein 
expression was modulated by gintonin treatment, we treated 
cells with either gintonin (1, 10 μg/ml) and gintonin with LPA1/3 
receptor antagonist (3 μM Ki16425) from DIV1 and collected 
them at DIV5 for Western blot with medium change of every 
other day. Consistent with the qPCR results, no significant 
changes were found in MBP protein expression by gintonin 
treatment (1, 10 μg/ml) as well as by LPA 1/3 receptor antagonist 
(Ki16425) (Figures 3F, H, Supplementary Figure S3), unlike 
proliferating OPCs (Figure 2).
ERK signaling is one of the main signal transduction 
pathways in oligodendrocytes (Guardiola-Diaz et al., 2012). 
To know whether gintonin-mediated changes occurred 
through ERK pathway, we prepared same samples as above 
and performed immunoblot for pERK and ERK antibodies 
(Figures 3G, I, Supplementary Figure S4). No significant 
changes by gintonin treatment in ERK phosphorylation were 
observed. Interestingly, ERK phosphorylation was significantly 
increased by 3 μM Ki16425 together with 1 μg/ml gintonin but 
not with 10 μg/ml gintonin. This suggests that LPA1/3 inhibition 
activates ERK phosphorylation but prolonged incubation with 
high concentrations (10 μg/ml) of gintonin might reverse ERK 
phosphorylation-related signaling.
Oligodendrocyte lineage cells go through several stages 
from proliferating precursor cells to mature myelinating 
oligodendrocytes. Various factors affect each stage, regulating 
myelin homeostasis in the brain (Bergles and Richardson, 2016). 
To evaluate whether there were changes in the developmental 
stages, which are mainly morphological and hard to identify by 
sample measurements using techniques such as real-time PCR 
or Western blot, we performed immunocytochemistry using 
FIGURE 3 | Gintonin does not change the expression of transcription factors at early stage of oligodendrocyte development. For differentiation analysis, isolated 
OPC s were treated with gintonin or Ki16425 or both of them as indicated during DIV1–3 (A–E) or DIV1–5 (F–I). Medium was changed every two days. (A–E) At 
DIV3, RNA expression of inhibitory (A, B), facilitatory (C, D) transcription factors of oligodendrocyte differentiation and myelin gene expression (E) were investigated 
on OPC cultures by real-time PCR. (F–I) At DIV5, protein expression levels of MBP (F, H) and phospho ERK (pERK) (G, I) were investigated on OPC cultures by 
Western blot. Protein bands of ERK and pERK are indicated by red arrows (I). No significant changes were found by gintonin treatment in the real-time PCR or 
Western blot analysis. Bars represent mean ± S.E.M.
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stage-specific markers of O4 (for immature and mature stages) 
and MBP (for mature stage) (Figure 4A). Pure OPC cultures were 
treated with dimethyl sulfoxide (DMSO) or 10 μg/ml gintonin in 
differentiation medium from DIV1 and fixed on DIV3 for analysis. 
Consistent with the proliferation results (Figures 1 and 2), 
gintonin was found to cause higher cell proliferation even in 
FIGURE 4 | Gintonin facilitates the late stage differentiation of oligodendrocytes. (A) For stage-specific differentiation analysis, pure OPC cultures treated with gintonin 
(10 μg/ml) or DMSO from DIV1 were lively stained at DIV3 with O4 antibodies (a marker for oligodendrocytes from immature stage, red), then allowed to fix for MBP 
(a mature oligodendrocyte marker, green) and DAPI (a nucleic marker, blue) staining. Scale bar＝10 µm. (B) In differentiation medium, DAPI+ cell number per field 
was significantly increased by gintonin treatment (*p < 0.05). (C) O4+ area per field by gintonin treatment. (D) MBP+ area per field was significantly enhanced by 
gintonin (**p < 0.01). (E) O4+ area per DAPI+ cell number (*p < 0.05). (F) MBP+ area per DAPI+ cell number. (G) MBP+ area per O4+ area was calculated as late 
differentiation ratio and was significantly increased by gintonin treatment (*p < 0.05). Bars represent mean ± S.E.M. Two-tailed unpaired Student’s t-test, N = 3–4.
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differentiation medium (Figure 4B). O4+ area per field was not 
significantly changed by gintonin treatment (Figure 4C), resulting 
in lower O4+ area per cell (Figure 4E), suggesting that gintonin 
does not affect early oligodendrocyte differentiation. Interestingly, 
MBP+ area per field was significantly higher in gintonin treatment 
compared to the control (Figure 4D). As DAPI+ cell number was 
high in gintonin-treated cultures (Figure 4B), MBP+ area per cell 
was not significantly different (Figure 4F). However, MBP+ area/
O4+ area, which indicates the ratio of mature oligodendrocytes 
among immature–mature oligodendrocytes, showed higher value 
in gintonin-treated cultures compared to DMSO controls (Figure 
4G). This suggests that gintonin may facilitate the differentiation 
in the late stages of oligodendrocyte development. Moreover, the 
effects of gintonin on late stage differentiation was not significantly 
related with the concentration of gintonin (Supplementary 
Figure 5), distinct with its effects on OPC proliferation (Figure 
1E), implying that gintonin may work through a different 
mechanism in each condition.
Gintonin Protects Oligodendrocyte Lineage 
Cells From ER Stress-Induced Cytotoxicity 
and Drives Recovery of Oligodendocyte-
Differentiation Gene Expression
Under ER stress, which is a critical factor in causing myelin 
diseases (Lucchinetti et al., 1999), translation in oligodendrocytes 
is repressed (Harding et al., 2000), which leads the cell death (Lin 
and Popko, 2009). Gintonin has been reported to protect neurons 
against death and act as an anti-inflammatory and anti-oxidant 
agent (Choi et al., 2018). To know whether gintonin plays a role 
in protecting oligodendrocytes under ER stress, we next incubated 
OPCs with gintonin at various concentrations (0, 0.1, 1, 10, 100 
μg/ml) under overnight ER stress induced by 5 μg/ml tunicamycin 
treatment during DIV1–2, and measured the cytotoxicity 
using LDH assays. Tunicamycin increased the expression of 
ER stress marker BIP in our system (Supplementary Figure 6). 
Tunicamycin-induced cytotoxicity was significantly reduced by 
gintonin at 0.1, 1, and 10 μg/ml (Figure 5A). This suggests that 
gintonin of 0.1–10 μg/ml can protect oligodendrocytes under 
ER stress.
Under ER stress, translation is repressed, resulting in low 
protein expression. To evaluate whether gintonin changes this 
phenotype, we incubated OPCs with tunicamycin for inducing 
ER stress during DIV1–5 while the medium was changed 
every 2 days. Protein expression was measured with β-actin. 
As expected, beta actin expression was dramatically reduced 
by tunicamycin treatment (Figures 5B, C, Supplementary 
Figure S7). Interestingly, gintonin dose-dependently increased 
β-actin expression (Figures 5B, C), suggesting that gintonin 
might release the repression of gene expression under ER stress. 
Moreover, we found Ki16425, which we initially used as an 
inhibitor of gintonin strongly alleviated the repression, resulting 
in higher β-actin expression. This suggests that inhibition of 
LPA1/3 by Ki16425 may also facilitate the gene expression under 
ER stress.
As gintonin subdued the repression of gene expression under 
ER stress, we wondered whether it was also applicable to myelin-
related gene expression. We investigated myelin-related gene 
expression in pure OPC culture at DIV3 as well as myelinating 
DRG/OPC coculture at DIV13. At DIV3 of OPC culture, 2 μg/ml 
tunicamycin significantly reduced MBP expression (Figure 6A). 
Interestingly, the expression was reversed by 1 μg/ml gintonin in 
the same condition (Figure 6B).
FIGURE 5 | Gintonin protects oligodendrocyte lineage cells against ER stress-induced cytotoxicity. (A) Oligodendrocyte precursor cell (OPC) cultures were treated 
with gintonin of various concentrations (0.1, 1, 10, 100 μg/ml) under 5 μg/ml tunicamycin during DIV 1–2 and LDH assay was performed at DIV2 (*p < 0.05,  
N = 3). (B, C) OPC cultures were exposed to long term ER stress induced by tunicamycin during DIV1–5 with or without gintonin or LPA inhibitors of indicated 
concentrations and submitted to Western blot analysis (B) and the expression quantification of beta actin was performed (C). Bars represent mean ± S.E.M.
Effects of Gintonin on Functions of OligodendrocytesMijan et al.
9 October 2019 | Volume 10 | Article 1211Frontiers in Pharmacology | www.frontiersin.org
FIGURE 6 | Gintonin reverses the repressed expression of myelin forming-facilitatory genes under ER stress, potentially by modulating UPR responses. 
Oligodendrocyte precursor cell (OPC) cultures (A and B) or DRG neurons/OPC myelinating cocultures (C–K) were treated with gintonin of the indicated 
concentrations from DIV1 and ER stress was induced by tunicamycin at the final overnight before the collection of total RNA. At DIV3 of OPC, the expression of 
MBP was investigated (A and B). **p < 0.01, Two-tailed unpaired Student’s t-test, N = 3. At DIV 13 of DRG/OPC cocultures, the expression of myelin forming-
facilitatory genes such as Olig1 (C), Myrf (D), MBP (E), CNP (F), and PLP (G) as well as unfolded protein response-related genes such as BIP (H), GRP94  
(I), CHOP (J), sXBP-1(K) were examined. *p < 0.05, One way ANOVA, Tukey post-test, N = 3. Bars represent mean ± S.E.M.
Effects of Gintonin on Functions of OligodendrocytesMijan et al.
10 October 2019 | Volume 10 | Article 1211Frontiers in Pharmacology | www.frontiersin.org
As OPC cultures at DIV3 contain a mixed population of 
premature and mature oligodendrocytes, we wondered whether 
gintonin affects the expression of mature oligodendrocytes 
under ER stress in the myelinating cultures. To find the answer, 
OPCs were seeded on dissociated DRG neuronal cultures 
and the co-cultures were incubated with gintonin at various 
concentrations (0, 0.1, 1, 10 μg/ml). The cultures were treated 
with 5 μg/ml tunicamycin overnight during DIV12–13, and the 
samples were collected at DIV13 for real-time PCR against Olig1 
(transcription factor for myelinating oligodendrocytes and their 
progenitors), Myrf (transcription factor for oligodendrocyte 
differentiation and myelination), MBP, PLP (compact myelin 
genes), and CNP (non-compact myelin gene). The expression 
of myelin-related genes were dramatically suppressed by 
tunicamycin treatment (Figures 6C–G). However, gintonin 
treatment reversed the repression of gene expression under ER 
stress, resulting in increased Olig1 (Figure 6C), Myrf (Figure 6D), 
and CNP (Figure 6F) gene expression, as well as mild alterations 
in MBP (Figure 6E) and PLP (Figure 6G) gene expression. The 
expression of ER stress markers such as BIP, GRP94, CHOP, and 
sXBP-1 was increased by tunicamycin, whereas their expression 
was mildly reduced by gintonin treatment (Figures 6H–K). 
Current results suggest that gintonin protects oligodendrocyte 
lineage cells from ER stress-induced cytotoxicity and enhances 
the recovery of oligodendrocyte-differentiation gene expression 
under ER stress.
DISCUSSION
Gintonin contains multiple components. These include 
phospholipid derivatives such as LPA C18:2 (434 nmol/g weight 
ginseng), LPA C16:0 (49 nmol/g weight ginseng), and other LPAs 
(below the sensitivity limit); proteins such as ginseng major latex-
like protein and ribonuclease-like storage protein (Hwang et al., 
2012); fatty acids such as linoleic, palmitic, oleic, and stearic acids; 
and carbohydrates such as glucose and glucosamine (Mi Kyung 
Pyo et al., 2011). Gintonin activates LPA receptor-mediated 
calcium signaling in B103 rat neuroblastoma cells (Hwang et al., 
2012) and stimulates human umbilical vascular endothelial cell 
proliferation in a concentration-dependent manner via LPA1/3 
receptor activation (Hwang et al., 2016).
OPCs highly express LPA1, LPA4, LPA6, and LPA8 (also 
known as P2Y10) (Nakajima et al., 2018). In primary mouse 
OPC cultures, LPA 18:1 or analog of cyclic phosphatidic acid, 
whose structure is similar to that of LPA, stimulated OPC 
proliferation but did not change expression of MBP or CNP 
at DIV3 in differentiation conditions without growth factor 
(Nakajima et al., 2018).These findings are consistent with 
our results of proliferation (Figure 2G) and MBP expression 
(Figures 3E, F). Inhibition of LPA1 and LPA3 by Ki16425 
abolished the analog of cyclic phosphatidic acid-induced OPC 
proliferation (Nakajima et al., 2018). This is also in accordance 
with our results, where gintonin-induced OPC proliferation 
was inhibited by Ki16425 (Figure 2G). There, our results 
suggest that gintonin increases the OPC proliferation through a 
LPA1/3 receptor-mediated mechanism.
Some of the transcription factors, such as Olig2 and Sox10, are 
expressed throughout all the developmental stages, participating 
in different regulations at each stage (Emery and Lu, 2015). Olig2 
functions in specification to the oligodendrocyte lineage cells 
in neural precursor cells, and later plays a role in initiating the 
myelination cascade program (Emery and Lu, 2015). SOX10 
plays important roles in maintaining OPC populations during 
developmental stage (Finzsch et al., 2008), and it is a major 
determinant in the terminal differentiation of oligodendrocytes 
by interacting with several other proteins (Elbaz and Popko, 
2019). Previous studies have reported that LPAs also function 
in two different developmental stages: OPC proliferation 
(Nakajima et al., 2018) and differentiation (Wheeler et al., 2015). 
LPA stimulates OPC proliferation during the precursor stage 
(Nakajima et al., 2018), whereas it stimulates histone deacetylase 
1/2 activation during the differentiation stages; the latter represses 
the transcription inhibitors for oligodendrocyte differentiation, 
facilitating oligodendrocyte differentiation (Wheeler et al., 2015). 
We found that gintonin stimulates OPC proliferation (Figures 
1 and 2) as well as late-stage of oligodendrocyte differentiation 
(Figures 3 and 4). Current results of gintonin containing LPAs 
for its active components suggest that it functions in two different 
developmental stages of oligodendrocytes: the precursor stage and 
the transition stage from immature to mature oligodendrocytes.
However, while gintonin showed dose-dependent changes 
in OPC proliferation (Figure 1E), it did not show consistent 
dose-dependent changes in differentiated oligodendrocytes 
(Supplementary Figure 5) as well as ER stress-induced 
conditions (Figures 5 and 6). Gintonin is the complex of multiple 
components (Mi Kyung Pyo et al., 2011; Hwang et al., 2012). 
Gintonin seems to work through LPA receptors on OPCs by 
LPA1/3 (Figure 2G). As OPCs express enough LPA receptors 
which may be activated by input LPAs (Nakajima et al., 2018), 
OPC proliferation seems to present dose-dependent changes 
within the used dose. Gene expression dramatically changes when 
OPCs are differentiated into mature oligodendrocytes (Emery 
and Lu, 2015). We did not see consistent gintonin dose-dependent 
changes in differentiated oligodendrocytes (Supplementary 
Figure 5) as well as in ER stress environments (Figures 5 and 6). 
This suggests that other components of gintonin in addition to 
LPA1/3 may also function in mature oligodendrocytes or stress 
condition. Moreover, this indicates that the expression or activity 
of the receptor against the specific components may reach 
threshold in the dose used in the experiments, resulting in not 
showing dose-dependent alterations.
To maintain myelin structure, oligodendrocytes produce 
huge amounts of proteins and lipid-rich membranes, which 
make them susceptible to ER stress. The unfolded protein 
response (UPR), which is an initial cell response to ER stress, is 
cell protective; however, prolonged stress lead to apoptotic cell 
death. In demyelinating diseases including multiple sclerosis, 
vanishing white matter disease, Charcot–Marie–Tooth disease, 
and Pelizaeus–Mezbarcher disease, robust evidence showing 
that ER stress contributes to the pathology is available (Clayton 
and Popko, 2016). Alterations in the UPR response by inhibiting 
GADD34 function, such as by using guanabenz, protected cells 
against ER stress (Tsaytler et al., 2011). GRP94, BiP, ATF4, CHOP 
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expression induced by tunicamycin treatment was downregulated 
by guanabenz, confirming protection against cell death (Tsaytler 
et al., 2011). We have found that gintonin increased gene 
expression, which was repressed during tunicamycin-induced 
ER stress (Figures 5 and 6). Under ER stress in the myelinating 
co-cultures, facilitatory gene expression for myelin formation was 
increased (Figures 6C–G), while ER stress marker expression was 
relatively reduced (Figures 6H–K) by gintonin treatment. This 
effect potentially contributed to protect OPCs from ER stress–
induced cell death (Figure 5A), suggesting cell-protective effects 
of gintonin under ER stress. Our study indicates that gintonin 
may affect protein expression by modulating UPR under ER 
stress and prevent ER stress-induced cell deaths. This suggests 
that gintonin or gintonin-derived components can be utilized 
for myelin maintenance or protection in the demyelinating 
disorders. Therefore, it is meaningful to investigate the effects of 
gintonin on myelin homeostasis in demyelination animal models 
such as lysolecithin or cuprizone models for future studies.
CONCLUSION
This is the first detailed study of the effects of gintonin on 
oligodendrocyte lineage cells. Our results show that gintonin 
increases proliferation of OPCs via LPA1/3 receptors, facilitates late-
stage differentiation, and protects oligodendrocyte lineage cells from 
cell death under ER stress by modulating the UPR response. Our 
findings warrant further studies to identify the detailed molecular 
mechanisms underlying gintonin’s effects on oligodendrocyte lineage 
cells and to investigate its in vivo functions using myelin-disease 
animal models for further therapeutic applications in myelin diseases.
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SUPPLEMENTARY FIGURE 1 | Time- and concentration-dependent changes 
in proliferating and total oligodendrocyte lineage cell number. Pure OPCs were 
isolated from glia mixed culture at DIV 10 and seeded on PDL-coated coverslips, 
and incubated with gintonin of the indicated concentrations from DIV1 and 
fixed at the indicated time point for staining of Ki67 (proliferation marker) or 
DAPI (nucleic marker). Proliferating (A, C, E, H) and total cells (B, D, F, I) were 
automatically counted by image J. Bars represent mean ± S.E.M. *p < 0.05, One 
way ANOVA, Tukey post-test, N = 3.
SUPPLEMENTARY FIGURE 2 | No effects of Ki16425 on cell survival in 
physiological condition of OPC cultures. (A and B) Oligodendrocyte precursor 
cell (OPC) cultures were incubated with control or Ki16425 as indicated during 
DIV1–3 in proliferation medium. Scale bar, 100 μm. (C) The number of DAPI-
positive cells were counted. Bars represent mean ± S.E.M.
SUPPLEMENTARY FIGURE 3 | Expression analysis of myelin protein expression 
by gintonin and LPA 1/3 inhibitor. Oligodendrocyte precursor cell (OPC) cultures 
were incubated with gintonin and/or Ki16425 as indicated during DIV1–5. Fresh 
medium was provided every two days. 7.6 × 104 OPCs per well in the 24-well plate 
were seeded and collected by 50 μl of 5× sample buffer per well. For Western blot, 
9 μl (A–H) or 3 μl (I–L) of samples was loaded and immunoblotted with antibodies 
against MBP (A and B, E and F, I and J). Antibodies on the membrane were stripped 
and reblotted with antibodies against beta actin (C and D, G and H, K and L).
SUPPLEMENTARY FIGURE 4 |Phosphorylation analysis of ERK by long term 
treatment of gintonin. Same sample preparation as in Supplementary Figure 3 was 
performed. Different antibodies were used for immunoblot; antibodies against phospho 
ERK (A and B, E and F, I and J) and ERK (C and D, G and H, K and L) were used.
SUPPLEMENTARY FIGURE 5 | Gintonin does not induce dose-dependence 
changes in the late stage differentiation of oligodendrocytes. (A–C) For stage-
specific differentiation analysis, pure OPC cultures treated with gintonin (1, 10 μg/ml)  
or DMSO from DIV1 were lively stained at DIV3 with O4 (red) antibodies, then 
allowed to fix for MBP (green) and DAPI (blue) staining. Scale bar = 100 µm. (D) 
DAPI+ cell number per field by gintonin treatment. (E) O4+ area per field by gintonin 
treatment. (F) MBP+ area per field by gintonin. (G) O4+ area per DAPI+ cell number 
(*p < 0.05). (H) MBP+ area per DAPI+ cell number. (I) MBP+ area per O4+ area. 
Bars represent mean ± S.E.M. One way ANOVA, Tukey post-test, N = 3–4.
SUPPLEMENTARY FIGURE 6 | The expression of ER stress marker BiP is 
induced by tunicamycin. (A) In our system, the expression of ER stress marker 
BiP was confirmed by tunicamycin treatment on OPC cultures at DIV4. Western 
blot image shows results from two different primary cultures (#1, #2). ERK is 
shown for loading control.
SUPPLEMENTARY FIGURE 7 | Modulation of gintonin on protein expression under 
in vitro chronic ER stress. (A–D) Oligodendrocyte precursor cell (OPC) cultures were 
incubated with gintonin and/or Ki16425 as indicated during DIV1–5 under chronic 
ER stress induced by tunicamycin. Fresh medium was provided every two days. 
Protein expression was investigated by β-actin. Three independent experiments were 
performed (A–C) and summarized in one graph (D).  Bars represent mean ± S.E.M.
Effects of Gintonin on Functions of OligodendrocytesMijan et al.
12 October 2019 | Volume 10 | Article 1211Frontiers in Pharmacology | www.frontiersin.org
REFERENCES
Allard, J., Barron, S., Diaz, J., Lubetzki, C., Zalc, B., Schwartz, J. C., et al. (1998). 
A rat G protein-coupled receptor selectively expressed in myelin-forming cells. 
Eur. J. Neurosci. 10, 1045–1053. doi: 10.1046/j.1460-9568.1998.00117.x
Bergles, D. E., and Richardson, W. D. (2016). Oligodendrocyte development and 
plasticity. Cold Spring Harb. Perspect. Biol. 8, a020453, 1–27. doi: 10.1101/
cshperspect.a020453
Boyd, A., Zhang, H., and Williams, A. (2013). Insufficient OPC migration into 
demyelinated lesions is a cause of poor remyelination in MS and mouse models. 
Acta Neuropathol. 125, 841–859. doi: 10.1007/s00401-013-1112-y
Bradl, M., and Lassmann, H. (2010). Oligodendrocytes: biology and pathology. 
Acta Neuropathol. 119, 37–53. doi: 10.1007/s00401-009-0601-5
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, 
K. S., et al. (2008). A transcriptome database for astrocytes, neurons, and 
oligodendrocytes: a new resource for understanding brain development and 
function. J. Neurosci. 28, 264–278. doi: 10.1523/JNEUROSCI.4178-07.2008
Chang, A., Nishiyama, A., Peterson, J., Prineas, J., and Trapp, B. D. (2000). 
NG2-positive oligodendrocyte progenitor cells in adult human brain 
and multiple sclerosis lesions. J. Neurosci. 20, 6404–6412. doi: 10.1523/
JNEUROSCI.20-17-06404.2000
Choi, J. H., Jang, M., Oh, S., Nah, S. Y., and Cho, I. H. (2018). Multi-target 
protective effects of gintonin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-
mediated model of parkinson’s disease via lysophosphatidic acid receptors. 
Front Pharmacol. 9, 515. doi: 10.3389/fphar.2018.00515
Choi, S. H., Kim, H. J., Cho, H. J., Park, S. D., Lee, N. E., Hwang, S. H., et al. 
(2019). Gintonin, a ginseng-derived exogenous lysophosphatidic acid receptor 
ligand, protects astrocytes from hypoxic and re-oxygenation stresses through 
stimulation of astrocytic glycogenolysis. Mol. Neurobiol. 56, 3280–3294. doi: 
10.1007/s12035-018-1308-1
Clayton, B. L. L., and Popko, B. (2016). Endoplasmic reticulum stress and the 
unfolded protein response in disorders of myelinating glia. Brain Res. 1648, 
594–602. doi: 10.1016/j.brainres.2016.03.046
Elbaz, B., and Popko, B. (2019). Molecular control of oligodendrocyte development. 
Trends Neurosci. 42, 263–277. doi: 10.1016/j.tins.2019.01.002
Emery, B., and Lu, Q. R. (2015). Transcriptional and epigenetic regulation of 
oligodendrocyte development and myelination in the central nervous system. 
Cold Spring Harb. Perspect. Biol. 7, a020461. doi: 10.1101/cshperspect.
a020461
Finzsch, M., Stolt, C. C., Lommes, P., and Wegner, M. (2008). Sox9 and Sox10 
influence survival and migration of oligodendrocyte precursors in the spinal 
cord by regulating PDGF receptor alpha expression. Development 135, 637–
646. doi: 10.1242/dev.010454
Guardiola-Diaz, H. M., Ishii, A., and Bansal, R. (2012). Erk1/2 MAPK and 
mTOR signaling sequentially regulates progression through distinct stages of 
oligodendrocyte differentiation. Glia 60, 476–486. doi: 10.1002/glia.22281
Harding, H. P., Novoa, I., Zhang, Y., Zeng, H., Wek, R., Schapira, M., et al. (2000). 
Regulated translation initiation controls stress-induced gene expression in 
mammalian cells. Mol. Cell 6, 1099–1108. doi: 10.1016/S1097-2765(00)00108-8
Hughes, E. G., and Appel, B. (2016). The cell biology of CNS myelination. Curr. 
Opin. Neurobiol. 39, 93–100. doi: 10.1016/j.conb.2016.04.013
Hwang, S. H., Lee, B. H., Choi, S. H., Kim, H. J., Won, K. J., Lee, H. M., et al. 
(2016). Effects of gintonin on the proliferation, migration, and tube formation 
of human umbilical-vein endothelial cells: involvement of lysophosphatidic-
acid receptors and vascular-endothelial-growth-factor signaling. J. Ginseng 
Res. 40, 325–333. doi: 10.1016/j.jgr.2015.10.002
Hwang, S. H., Shin, T. J., Choi, S. H., Cho, H. J., Lee, B. H., Pyo, M. K., et al. (2012). 
Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic 
acids-protein complexes and activates G protein-coupled lysophosphatidic 
acid receptors with high affinity. Mol. Cells 33, 151–162. doi: 10.1007/
s10059-012-2216-z
Levine, J. M., Reynolds, R., and Fawcett, J. W. (2001). The oligodendrocyte 
precursor cell in health and disease. Trends Neurosci. 24, 39–47. doi: 10.1016/
S0166-2236(00)01691-X
Lin, W., and Popko, B. (2009). Endoplasmic reticulum stress in disorders of 
myelinating cells. Nat. Neurosci. 12, 379–385. doi: 10.1038/nn.2273
Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M., and 
Lassmann, H. (1999). A quantitative analysis of oligodendrocytes in multiple 
sclerosis lesions. A study of 113 cases. Brain 122 (Pt 12), 2279–2295. doi: 
10.1093/brain/122.12.2279
Mi Kyung Pyo, S.-H. C., Hwang, S. H., Shin, T.-J., Lee, Sang, B.-H., Mok 
Lee, Y.-H. L., Kim, D.-H., et al. (2011). , Novel glycolipoproteins from ginseng. 
J. Ginseng Res. 35, 92–103. doi: 10.5142/jgr.2011.35.1.092
Nakajima, S., Gotoh, M., Fukasawa, K., Murofushi, H., and Murakami Murofushi, K. 
(2018). 2-O-Carba-oleoyl cyclic phosphatidic acid induces glial proliferation 
through the activation of lysophosphatidic acid receptor. Brain Res. 1681, 
44–51. doi: 10.1016/j.brainres.2017.12.031
Tsaytler, P., Harding, H. P., Ron, D., and Bertolotti, A. (2011). Selective inhibition 
of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science 
332, 91–94. doi: 10.1126/science.1201396
Weiner, J. A., Hecht, J. H., and Chun, J. (1998). Lysophosphatidic acid receptor 
gene vzg-1/lpA1/edg-2 is expressed by mature oligodendrocytes during 
myelination in the postnatal murine brain. J. Comp Neurol. 398, 587–598. doi: 
10.1002/(SICI)1096-9861(19980907)398:4<587::AID-CNE10>3.0.CO;2-5
Wheeler, N. A., Lister, J. A., and Fuss, B. (2015). The autotaxin-lysophosphatidic 
acid axis modulates histone acetylation and gene expression during 
oligodendrocyte differentiation. J. Neurosci. 35, 11399–11414. doi: 10.1523/
JNEUROSCI.0345-15.2015
Yang, H. J., Vainshtein, A., Maik-Rachline, G., and Peles, E. (2016). G protein-
coupled receptor 37 is a negative regulator of oligodendrocyte differentiation 
and myelination. Nat. Commun. 7, 10884. doi: 10.1038/ncomms10884
Yu, N., Lariosa-Willingham, K. D., Lin, F. F., Webb, M., and Rao, T. S. (2004). 
Characterization of lysophosphatidic acid and sphingosine-1-phosphate-
mediated signal transduction in rat cortical oligodendrocytes. Glia 45, 17–27. 
doi: 10.1002/glia.10297
Conflict of Interest: The authors declare that the research was conducted in the 
absence of any commercial or financial relationships that could be construed as a 
potential conflict of interest.
Copyright © 2019 Mijan, Kim, Moon, Choi, Nah and Yang. This is an open-access 
article distributed under the terms of the Creative Commons Attribution License (CC 
BY). The use, distribution or reproduction in other forums is permitted, provided 
the original author(s) and the copyright owner(s) are credited and that the original 
publication in this journal is cited, in accordance with accepted academic practice. No 
use, distribution or reproduction is permitted which does not comply with these terms.
